STOCK INFO
NASDAQYI
Latest Releases
May 23, 2024

Turned to Quarterly Operational Profitability for the First Time Operating Expenses as a Percentage of Revenues Decreased 120 Basis Points YoY to 5.8% Achieved Positive Operating Cash Flow...

All Press Releases

Earnings

111, Inc. Executive Summary

Q1 2024 Earnings Webcast
Q1 2024 Earnings Release
Q1 2024 Earnings Presentation

CORPORATE PROFILE

111, Inc. listed on NASDAQ (YI:US) is a leading digital healthcare platform dedicating to digitally connecting patients with drugs and healthcare services in China.

The Company provides millions of consumers with better access to pharmaceutical products and healthcare services directly through its online retail pharmacy 1 Drugstore and indirectly through its offline virtual pharmacy network. The Company also offers online healthcare services through its internet hospital, 1 Clinic, which provides consumers with cost-effective and convenient online consultation, electronic prescription service and patient management service. In addition, the Company's online wholesale pharmacy, 1 Drug Mall, serves as a one-stop shop for pharmacies to source a vast selection of pharmaceutical products. With the largest virtual pharmacy network in China, 111 enables offline pharmacies to better serve their customers with cloud-based services. 111 also provides omni-channel support to its strategic partners in their drug commercialization effort, with services such as digital marketing, patient education, data analytics and pricing monitoring.

View All>

 

Company Introduction

 

IR Contacts

Primary IR Contact             

111, Inc.                             

E-mail: ir@111.com.cn       

Information Request

If you would like to receive our Investor Relations Packet,

including reprints of scientific publications relating to our products,

click here. Thank you for your interest.